Wei, S., Jespersen, M. L., Baunwall, S. M. D., Myers, P. N., Smith, E. M., Dahlerup, J. F., Rasmussen, S., Nielsen, H. B., Licht, T. R., Bahl, M. I. & Hvas, C. L. (2022). Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report. Microbiome, 10, Article 193. https://doi.org/10.1186/s40168-022-01394-w

Rubak, T., Baunwall, S. M. D., Gregersen, M., Hansen, T. K., Rosenbæk, J. B., Erikstrup, L. T., Hvas, C. L. & Damsgaard, E. M. S. (2023). Frailty level at discharge predicts mortality in older patients with Clostridioides difficile more accurately than age or disease severity. European Geriatric Medicine, 14(3), 583-593. https://doi.org/10.1007/s41999-023-00772-3

Rubak, T., Baunwall, S. M. D., Gregersen, M., Paaske, S. E., Asferg, M., Barat, I., Secher-Johnsen, J., Riis, M. G., Rosenbæk, J. B., Hansen, T. K., Ørum, M., Steves, C. J., Veilbæk, H., Hvas, C. L. & Damsgaard, E. M. S. (2024). Early geriatric assessment and management in older patients with Clostridioides difficile infection in Denmark (CLODIfrail): a randomised trial. The Lancet Healthy Longevity, 5(12), 100648. Article 100648. https://doi.org/10.1016/j.lanhl.2024.100648

Ravnborg, A. B., Hvas, C. L., Agnholt, J., Dahlerup, J. F., Vind, I., Till, A., Rosenstiel, P. & Höllsberg, P. (2009). Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways. Clinical and Experimental Immunology, 155, 487-95.

Paaske, S. E., Baumwall, S. M. D., Rubak, T., Birn, F. H., Rågård, N., Kelsen, J., Hansen, M. M., Svenningsen, L., Krarup, A. L., Fernis, C. M. C., Neumann, A., Lødrup, A. B., Glerup, H., Vinter-Jensen, L., Helms, M., Erikstrup, L. T., Grosen, A. K., Mikkelsen, S., Erikstrup, C. ... Hvas, C. L. (2025). Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection. Clinical Gastroenterology and Hepatology, 23(4), 602-611.e8. https://doi.org/10.1016/j.cgh.2024.05.038

Oppfeldt, A. M., Dahlerup, J. F., Christensen, L. A. & Hvas, C. L. (2016). Faecal microbiota transplantation for recurring Clostridium difficile infection in a patient with Crohn's disease and ileorectal anastomosis. BMJ Case Reports, 2016. https://doi.org/10.1136/bcr-2016-217209

Kelsen, J., Hvas, C. L., Agnholt, J. & Dahlerup, J. F. (2006). CD4⁺CD25⁺-regulatoriske T-celler og deres betydning for sygdomme hos mennesker. Ugeskrift for Læger, 168, 32-7.

Keller, J. J., Vehreschild, M. JGT., Hvas, C. L., Jørgensen, S. MD., Kupciskas, J., Link, A., Mulder, C. JJ., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P. (2019). Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug. United European Gastroenterology Journal, 7(10), 1408-1410. https://doi.org/10.1177/2050640619887579

Keller, J. J., Vehreschild, M. J., Hvas, C. L., Jørgensen, S. M., Kupcinskas, J., Link, A., Mulder, C. J., Goldenberg, S. D., Arasaradnam, R., Sokol, H., Gasbarrini, A., Hoegenauer, C., Terveer, E. M., Kuijper, E. J. & Arkkila, P. (2020). Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are needed. United European Gastroenterology Journal, 8(3), 353-354. https://doi.org/10.1177/2050640620910847

Keller, J. J., Ooijevaar, R. E., Hvas, C. L., Terveer, E. M., Lieberknecht, S. C., Högenauer, C., Arkkila, P., Sokol, H., Gridnyev, O., Mégraud, F., Kump, P. K., Nakov, R., Goldenberg, S. D., Satokari, R., Tkatch, S., Sanguinetti, M., Cammarota, G., Dorofeev, A., Gubska, O. ... Vehreschild, M. J. (2021). A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group. United European Gastroenterology Journal, 9(2), 229-247. https://doi.org/10.1177/2050640620967898

Jørgensen, S. M. D., Hansen, M. M., Erikstrup, C., Dahlerup, J. F. & Hvas, C. L. (2017). Faecal microbiota transplantation: establishment of a clinical application framework. European Journal of Gastroenterology and Hepatology, 29(11), 36-45. https://doi.org/10.1097/MEG.0000000000000958

Jørgensen, S. M. D., Hvas, C. L., Dahlerup, J. F., Mikkelsen, S., Ehlers, L., Hammeken, L. H., Licht, T. R., Bahl, M. I. & Erikstrup, C. (2019). Banking feces: a new frontier for public blood banks? Transfusion, 59(9), 2776-2782. https://doi.org/10.1111/trf.15422

Jørgensen, S. M. D., Rubak, T. M. M., Damsgaard, E. M., Dahlerup, J. F. & Hvas, C. L. (2020). Faecal microbiota transplantation as a home therapy to frail older people. Age and Ageing, 49(6), 1093-1096. https://doi.org/10.1093/ageing/afaa073

Ianiro, G., Mullish, B. H., Hvas, C. L., Segal, J. P., Kuijper, E. J., Costello, S. P., Kelly, C. R., Allegretti, J. R., Fischer, M., Iqbal, T. H., Satokari, R., Kao, D., Prehn, J. V., Ng, S. C., Bibbò, S., Baunwall, S. M. D., Quraishi, M. N., Sokol, H., Zhang, F. ... Cammarota, G. (2021). SARS-CoV-2 vaccines and donor recruitment for FMT. The Lancet Gastroenterology and Hepatology, 6(4), 264-266. https://doi.org/10.1016/S2468-1253(21)00032-7

Ianiro, G., Mullish, B. H., Iqbal, T. H., Terveer, E. M., Baunwall, S. M. D., Link, A., Sokol, H., Kupcinskas, J., Masucci, L., Sanguinetti, M., Vehreschild, M. J. G. T., Hvas, C. L., Keller, J. J., Gasbarrini, A., Kujiper, E. J. & Cammarota, G. (2022). Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel. The Lancet Gastroenterology and Hepatology, 7(11), 979-980. https://doi.org/10.1016/S2468-1253(22)00305-3

Hvas, C. L., Kelsen, J., Agnholt, J., Höllsberg, P., Tvede, M., Møller, J. K. & Dahlerup, J. F. (2007). Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria. Scandinavian Journal of Gastroenterology, 42, 592-601.

Hvas, C. L. (2016). Fæcestransplantation: afføring fra raske donorer som behandling af akutte og kroniske sygdomme. Månedsskrift for Almen Praksis, 94(3), 203-211.

Hvas, C. L., Dige, A., Bendix Rasch, M., Wernlund, P. G., Christensen, L. A., Dahlerup, J. F. & Agnholt, J. (2016). Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study. European Journal of Clinical Investigation, 46(6), 555-63. https://doi.org/10.1111/eci.12634

Hvas, C. L., Borre, M. & Fassov, J. (2017). Ernæring og kosttilskud ved kronisk inflammatorisk tarmsygdom. Ugeskrift for Læger, 179(22), 2-6. http://ugeskriftet.dk/videnskab/ernaering-og-kosttilskud-ved-kronisk-inflammatorisk-tarmsygdom

Hvas, C. L., Farrer, K., Blackett, B., Lloyd, H., Paine, P. & Lal, S. (2018). Reduced 30-day gastrostomy placement mortality following the introduction of a multidisciplinary nutrition support team: a cohort study. Journal of Human Nutrition and Dietetics, 31(3), 413-421. https://doi.org/10.1111/jhn.12520